13F manager/RYTM/

PRIMECAP Management add RHYTHM PHARMACEUTICALS, INC.

PRIMECAP Management add $430.5M of disclosed value in RHYTHM PHARMACEUTICALS, INC..

Signal
Investor Move
Action
Add
Capital
$430.5M disclosed value

Why it matters

This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.

Evidence